We serve Chemical Name:1-(1H-Imidazol-2-yl)ethanamine CAS:1154736-07-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(1H-Imidazol-2-yl)ethanamine
CAS.NO:1154736-07-8
Synonyms:1-(1H-Imidazol-2-yl)ethanamine
Molecular Formula:C5H9N3
Molecular Weight:111.14500
HS Code:2933290090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:54.70000
Exact Mass:111.08000
LogP:1.12970
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(1H-Imidazol-2-yl)ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(1H-Imidazol-2-yl)ethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(1H-Imidazol-2-yl)ethanamine Use and application,1-(1H-Imidazol-2-yl)ethanamine technical grade,usp/ep/jp grade.
Related News: At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity. 1-(1H-Imidazol-2-yl)ethanamine manufacturer The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. 1-(1H-Imidazol-2-yl)ethanamine supplier During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. 1-(1H-Imidazol-2-yl)ethanamine vendor The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 1-(1H-Imidazol-2-yl)ethanamine factory The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.
